nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure
|
Costanzo, Maria Rosa |
|
2016 |
4 |
2 |
p. 95-105 |
artikel |
2 |
Death of the Heart Failure Clinical Investigator
|
O’Connor, Christopher M. |
|
2016 |
4 |
2 |
p. 162-163 |
artikel |
3 |
Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure
|
Zipes, Douglas P. |
|
2016 |
4 |
2 |
p. 129-136 |
artikel |
4 |
Does What Happens During Sleep Matter for the Failing Heart? ∗
|
Cowie, Martin R. |
|
2016 |
4 |
2 |
p. 126-128 |
artikel |
5 |
Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction
|
Fiuzat, Mona |
|
2016 |
4 |
2 |
p. 109-115 |
artikel |
6 |
Influenza Vaccination in Patients With Chronic Heart Failure
|
Vardeny, Orly |
|
2016 |
4 |
2 |
p. 152-158 |
artikel |
7 |
Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure
|
Arzt, Michael |
|
2016 |
4 |
2 |
p. 116-125 |
artikel |
8 |
Spinal Cord Stimulation for Heart Failure in the DEFEAT-HF Study
|
Upadhyay, Gaurav A. |
|
2016 |
4 |
2 |
p. 137-139 |
artikel |
9 |
The PARADIGM of Influenza Vaccination in Heart Failure Patients ∗
|
Acharya, Deepak |
|
2016 |
4 |
2 |
p. 159-161 |
artikel |
10 |
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF
|
Edelmann, Frank |
|
2016 |
4 |
2 |
p. 140-149 |
artikel |
11 |
Understanding Mechanisms of Action of Beta-Blockers in Heart Failure With Reduced and Preserved Ejection Fraction ∗
|
Flather, Marcus D. |
|
2016 |
4 |
2 |
p. 150-151 |
artikel |
12 |
When Business and Science Clash, How Can We Avoid Harming Patients?
|
Mark, Daniel B. |
|
2016 |
4 |
2 |
p. 106-108 |
artikel |